CITI Training Practice Exam

Question: 1 / 400

Which phase aims to examine a drug's short-term risks and preliminary effectiveness?

Phase I

Phase II

Phase II aims to examine a drug's short-term risks and preliminary effectiveness. During this phase, the drug is tested on a larger group of people, typically 100-300, to gather more data on its safety and effectiveness. Phase II also helps to determine the optimal dosage of the drug.

A) Phase I tests a drug on a small group of healthy volunteers and focuses on its safety and potential side effects.

C) Phase III tests the drug on a larger group of patients to further evaluate its effectiveness and safety, as well as compare it to current treatments.

D) Phase IV, also known as post-marketing surveillance, is conducted after the drug has been approved for use and aims to evaluate long-term side effects and effectiveness. Therefore, none of these phases are focused solely on short-term risks and preliminary effectiveness, making them incorrect options.

Get further explanation with Examzify DeepDiveBeta

Phase III

Phase IV

Next Question

Report this question

Download CITI Training Practice Exam PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy